FreeStyle Libre Monitoring in T2DM

NCT05597293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if blood sugar monitoring using a FreeStyle Libre device can improve overall Diabetes control in people with Type 2 Diabetes.

The main questions it aims to answer are:

* What is the effect of monitoring using the FreeStyle Libre device for a period of 12 weeks on the blood sugar control of people with Type 2 Diabetes?
* Can monitoring using the FreeStyle Libre device improve the quality of life of people with Type 2 diabetes?

Participants will be asked to wear one of two brands of FreeStyle Libre devices. In one group, participants will have 3 visits, while those in the second group, they will have 4 visits.

Researchers will compare the improvement in the sugar control for the individuals but also compare between the 2 groups.

Conditions

  • Type2diabetes

Interventions

DEVICE

Glucose monitoring using FreeStyle Libre 2

Glucose monitoring in patients with type 2 diabetes using FreeStyle Libre 2

DEVICE

Glucose monitoring using FreeStyle Libre pro iQ

Glucose monitoring in patients with type 2 diabetes using FreeStyle Libre pro iQ

Sponsors & Collaborators

  • University of Hull

    lead OTHER

Principal Investigators

  • Thozhukat Sathyapalan, FRCP,FACP · University of Hull

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2024-03-11
Completion
2024-05-02
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05597293 on ClinicalTrials.gov